3 UK Stocks That May Be Trading Below Estimated Value

The UK stock market has recently experienced some turbulence, with the FTSE 100 and FTSE 250 indices closing lower amid weak trade data from China and global economic concerns. In such an environment, identifying stocks that may be trading below their estimated value can present opportunities for investors seeking to capitalize on potential mispricings in the market.

Top 10 Undervalued Stocks Based On Cash Flows In The United Kingdom

Click here to see the full list of 58 stocks from our Undervalued UK Stocks Based On Cash Flows screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Fintel (AIM:FNTL)

Overview: Fintel Plc provides intermediary services and distribution channels to the retail financial services sector in the United Kingdom, with a market cap of £255.27 million.

Operations: The company generates revenue from three main segments: Research & Fintech (£25.40 million), Distribution Channels (£23.80 million), and Intermediary Services (£29.10 million).

Estimated Discount To Fair Value: 39.3%

Fintel is trading at £2.45, significantly below its estimated fair value of £4.04, indicating potential undervaluation based on cash flows. Despite a drop in net income to £5.9 million from £7.1 million last year, earnings are projected to grow substantially at 30.15% annually over the next three years, outpacing the UK market's growth rate. However, profit margins have decreased from 10.9% to 7.5%, and leadership changes may impact strategic direction with Matt Timmins becoming sole CEO by mid-2025.

• In light of our recent growth report, it seems possible that Fintel's financial performance will exceed current levels.
• Click to explore a detailed breakdown of our findings in Fintel's balance sheet health report.

NIOX Group (AIM:NIOX)

Overview: NIOX Group Plc is involved in the design, development, and commercialization of medical devices for measuring fractional exhaled nitric oxide (FeNo) globally, with a market cap of £300.08 million.

Operations: NIOX Group Plc generates revenue through the global design, development, and commercialization of medical devices used for measuring fractional exhaled nitric oxide (FeNo).

Estimated Discount To Fair Value: 45.5%

NIOX Group, trading at £0.75, is significantly undervalued with an estimated fair value of £1.38 based on discounted cash flow analysis. Despite a decline in net income to £3.7 million from £10.7 million last year, earnings are forecasted to grow 43.66% annually over the next three years, surpassing the UK market's growth rate of 14%. Recent acquisition interest by Keensight Capital and executive changes could influence future performance and strategic direction.

• Our comprehensive growth report raises the possibility that NIOX Group is poised for substantial financial growth.
• Click here to discover the nuances of NIOX Group with our detailed financial health report.

Bridgepoint Group (LSE:BPT)

Overview: Bridgepoint Group plc is a private equity and private credit firm focusing on middle market and small cap investments, with a market cap of £2.64 billion.

Operations: The company's revenue is derived from its segments in Private Equity (£275.60 million), Credit (£75.70 million), and Infrastructure (£72.50 million).

Estimated Discount To Fair Value: 10.7%

Bridgepoint Group, trading at £3.2, is undervalued with a fair value estimate of £3.58 based on discounted cash flow analysis. Despite a dip in net income to £64.8 million from £70.7 million, earnings are expected to grow 32.6% annually, exceeding the UK market's 14% growth rate. Recent rumors suggest a potential €500 million sale of Evac Oy could impact cash flows and strategic focus as revenue continues to outpace the broader market growth rate at 14.2%.

• Insights from our recent growth report point to a promising forecast for Bridgepoint Group's business outlook.
• Unlock comprehensive insights into our analysis of Bridgepoint Group stock in this financial health report.

Taking Advantage

• Get an in-depth perspective on all 58 Undervalued UK Stocks Based On Cash Flows by using our screener here.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com